ApiJect
ApiJect uses blow-fill-seal aseptic filling and high-precision plastic injection moulding to manufacture innovative injection devices that provide the convenience, quality and safety of prefilled syringes at the manufacturing scale and cost-efficiency of multi-dose formats, regardless of manufacturing volume.
ApiJect is a global medical technology company that aims to create the future of pharmaceutical injections. The company’s mission is to provide products with the superior convenience, quality and safety of prefilled syringes at the manufacturing scale and cost-efficiency of multi-dose formats, regardless of manufacturing volume.
ApiJect’s platform brings together two globally trusted manufacturing technologies – Blow-Fill-Seal aseptic filling and high-precision plastic injection moulding. The company’s supply chain is simple and compact, using widely available raw materials, ensuring reliability and resilience.
The company was founded in 2018 by Marc Koska, inventor of the K1 auto-disable syringe. It is privately owned.
Authors and Contacts
Article
